As part of a new interstate project, specialists from the A.P. Nelyubin Institute of Pharmacy at Sechenov First Moscow State Medical University and one of the leading technical universities in Southeast Asia (Bandung Institute of Technology) will focus on developing advanced nanopharmaceutical forms: nanoemulsions, nanosuspensions, and lamellar emulsions. The systems are designed for the therapy of dermatological pathologies, including dermatitis, xerosis, and impaired skin barrier integrity.
The key competitive advantage of the partnership, as noted in the press service of Sechenov University, is the Russian side's access to the unique phytochemical base of Indonesia. Researchers plan to integrate extracts of endemic tropical plants into the composition of innovative transport carriers being developed on the "Equator" platform.
Of particular scientific interest within the project are lamellar emulsions — structures capable of mimicking the lipid bilayer of cell membranes and promoting the restoration of the physiological barrier of the skin. Previously, the first domestic lamellar emulsion for dermatological use was successfully developed at Sechenov University, which creates a solid foundation for scaling up research.
The introduction of new technologies is aimed at ensuring targeted delivery of active pharmaceutical ingredients and controlling their release in target tissues. This will significantly increase the bioavailability and therapeutic effectiveness of topical preparations in the treatment of chronic and acute skin pathologies.
